1. Home
  2. VALN vs PEO Comparison

VALN vs PEO Comparison

Compare VALN & PEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • PEO
  • Stock Information
  • Founded
  • VALN 2012
  • PEO 1929
  • Country
  • VALN France
  • PEO United States
  • Employees
  • VALN N/A
  • PEO N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • PEO Finance/Investors Services
  • Sector
  • VALN Health Care
  • PEO Finance
  • Exchange
  • VALN Nasdaq
  • PEO Nasdaq
  • Market Cap
  • VALN 510.7M
  • PEO 596.4M
  • IPO Year
  • VALN 2021
  • PEO N/A
  • Fundamental
  • Price
  • VALN $6.79
  • PEO $20.32
  • Analyst Decision
  • VALN Strong Buy
  • PEO
  • Analyst Count
  • VALN 2
  • PEO 0
  • Target Price
  • VALN $16.00
  • PEO N/A
  • AVG Volume (30 Days)
  • VALN 142.9K
  • PEO 35.4K
  • Earning Date
  • VALN 05-06-2025
  • PEO 01-01-0001
  • Dividend Yield
  • VALN N/A
  • PEO 5.93%
  • EPS Growth
  • VALN N/A
  • PEO N/A
  • EPS
  • VALN N/A
  • PEO N/A
  • Revenue
  • VALN $175,564,758.00
  • PEO N/A
  • Revenue This Year
  • VALN $19.17
  • PEO N/A
  • Revenue Next Year
  • VALN $26.31
  • PEO N/A
  • P/E Ratio
  • VALN N/A
  • PEO N/A
  • Revenue Growth
  • VALN 10.32
  • PEO N/A
  • 52 Week Low
  • VALN $3.62
  • PEO $19.22
  • 52 Week High
  • VALN $9.50
  • PEO $23.80
  • Technical
  • Relative Strength Index (RSI)
  • VALN 50.63
  • PEO 43.24
  • Support Level
  • VALN $6.54
  • PEO $19.30
  • Resistance Level
  • VALN $7.30
  • PEO $20.54
  • Average True Range (ATR)
  • VALN 0.48
  • PEO 0.89
  • MACD
  • VALN 0.01
  • PEO -0.09
  • Stochastic Oscillator
  • VALN 56.79
  • PEO 42.27

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About PEO Adams Natural Resources Fund Inc.

Adams Natural Resources Fund Inc is a closed-end equity investment company specializing in energy and other natural resources stocks. The investment objectives of the fund are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. Its portfolio of investments comprises of different sector investments such as in the energy sector and basic materials.

Share on Social Networks: